1. Home
  2. RGEN vs FRT Comparison

RGEN vs FRT Comparison

Compare RGEN & FRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RGEN
  • FRT
  • Stock Information
  • Founded
  • RGEN 1981
  • FRT 1962
  • Country
  • RGEN United States
  • FRT United States
  • Employees
  • RGEN N/A
  • FRT N/A
  • Industry
  • RGEN Medical/Dental Instruments
  • FRT Real Estate Investment Trusts
  • Sector
  • RGEN Health Care
  • FRT Real Estate
  • Exchange
  • RGEN Nasdaq
  • FRT Nasdaq
  • Market Cap
  • RGEN 6.5B
  • FRT 8.2B
  • IPO Year
  • RGEN N/A
  • FRT N/A
  • Fundamental
  • Price
  • RGEN $119.39
  • FRT $99.24
  • Analyst Decision
  • RGEN Buy
  • FRT Buy
  • Analyst Count
  • RGEN 10
  • FRT 13
  • Target Price
  • RGEN $163.78
  • FRT $109.54
  • AVG Volume (30 Days)
  • RGEN 718.1K
  • FRT 582.8K
  • Earning Date
  • RGEN 11-11-2025
  • FRT 10-29-2025
  • Dividend Yield
  • RGEN N/A
  • FRT 4.42%
  • EPS Growth
  • RGEN N/A
  • FRT 16.00
  • EPS
  • RGEN N/A
  • FRT 3.96
  • Revenue
  • RGEN $673,956,000.00
  • FRT $1,239,059,000.00
  • Revenue This Year
  • RGEN $16.79
  • FRT $5.34
  • Revenue Next Year
  • RGEN $13.68
  • FRT $5.28
  • P/E Ratio
  • RGEN N/A
  • FRT $25.12
  • Revenue Growth
  • RGEN 8.73
  • FRT 6.05
  • 52 Week Low
  • RGEN $102.97
  • FRT $80.65
  • 52 Week High
  • RGEN $182.52
  • FRT $118.09
  • Technical
  • Relative Strength Index (RSI)
  • RGEN 49.56
  • FRT 51.64
  • Support Level
  • RGEN $112.73
  • FRT $99.94
  • Resistance Level
  • RGEN $122.71
  • FRT $102.31
  • Average True Range (ATR)
  • RGEN 4.85
  • FRT 1.48
  • MACD
  • RGEN -0.27
  • FRT -0.28
  • Stochastic Oscillator
  • RGEN 53.02
  • FRT 18.03

About RGEN Repligen Corporation

Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category and was 58% of 2024 revenue, while chromatography, proteins, and process analytics were 19%, 12%, and 9%, respectively. Customers in North America, Europe, and Asia Pacific contributed 44%, 37%, and 19% of revenue, respectively.

About FRT Federal Realty Investment Trust

Federal Realty Investment Trust is a shopping center-focused retail real estate investment trust that owns high-quality properties in eight of the largest metropolitan markets. Its portfolio includes an interest in 103 properties, which includes 27.5 million square feet of retail space and over 3,100 multifamily units. Federal's retail portfolio includes grocery-anchored centers, superregional centers, power centers, and mixed-use urban centers. Federal Realty has focused on owning assets in highly desirable areas with significant growth, and as a result, the average population density and average median household income are higher for its portfolio than for any other retail REIT.

Share on Social Networks: